Can animal models help to explore functions of nanoparticles in health and diseases?

References

• 1. Dong C, Ma A, Shang L. Nanoparticles for postinfarct ventricular remodeling. Nanomedicine (Lond.) 13(23), 3037–3050 (2018).
  CASGoogle Scholar
• 2. Gimondi S, Ferreira H, Reis RL, Neves NM. Microfluidic devices: a tool for nanoparticle synthesis and performance evaluation. ACS Nano 17(15), 14205–14228 (2023).
  Medline CASGoogle Scholar
• 3. Tenchov R, Bird R, Curtze AE, Zhou Q. Lipid nanoparticles horizontal line from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement. ACS Nano 15(11), 16982–17015 (2021).
  Medline CASGoogle Scholar
• 4. Bobo D, Robinson KJ, Islam J, Thurecht KJ, Corrie SR. Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date. Pharm. Res. 33(10), 2373–2387 (2016).
  Medline CASGoogle Scholar
• 5. Maynard LH, Humbert O, Peterson CW, Kiem HP. Genome editing in large animal models. Mol. Ther. 29(11), 3140–3152 (2021).
  Medline CASGoogle Scholar
• 6. Braakhuis HM, Kloet SK, Kezic S et al. Progress and future of in vitro models to study translocation of nanoparticles. Arch. Toxicol. 89(9), 1469–1495 (2015).
  Medline CASGoogle Scholar
• 7. Tang H, Zhang Y, Yang T et al. Cholesterol modulates the physiological response to nanoparticles by changing the composition of protein corona. Nat. Nanotechnol. 18(9), 1067–1077 (2023).
  Medline CASGoogle Scholar
• 8. Guo D, Ji X, Xie H et al. Targeted reprogramming of vitamin b(3) metabolism as a nanotherapeutic strategy towards chemoresistant cancers. Adv. Mater. 35(36), e2301257 (2023).
  Medline CASGoogle Scholar
• 9. Enkirch T, von Messling V. Ferret models of viral pathogenesis. Virology 479–480, 259–270 (2015).
  Medline CASGoogle Scholar
• 10. Weidenbacher PA, Sanyal M, Friedland N et al. A ferritin-based covid-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates. Nat. Commun. 14(1), 2149 (2023).
  Medline CASGoogle Scholar
• 11. Maier MA, Jayaraman M, Matsuda S et al. Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of rnai therapeutics. Mol. Ther. 21(8), 1570–1578 (2013).
  Medline CASGoogle Scholar
• 12. Lam K, Schreiner P, Leung A et al. Optimizing lipid nanoparticles for delivery in primates. Adv. Mater. 35(26), e2211420 (2023).
  Medline CASGoogle Scholar
• 13. Liao J, Tian T, Shi S et al. Broadening the biocompatibility of gold nanorods from rat to macaca fascicularis: advancing clinical potential. J. Nanobiotechnol. 19(1), 195 (2021).
  Medline CASGoogle Scholar
• 14. Lu Y, Xu YJ, Zhang GB et al. Iron oxide nanoclusters for t (1) magnetic resonance imaging of non-human primates. Nat. Biomed. Eng. 1(8), 637–643 (2017).
  Medline CASGoogle Scholar